Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 233 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cancer Lung Screening Clear all

Conditions: Non-Small Cell Lung Carcinoma, Compliance Behavior, Prevention Harmful Effects
Interventions: Patient Navigation; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 55 Years to 74 Years
Enrollment: 447 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Lung Cancer
Interventions: Transportation, Scheduling; Behavioral
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years to 89 Years
Enrollment: 252 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Lung Cancer
Interventions: ED-LCS; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Lung Cancer Screening
Interventions: Survey; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Lung Cancer
Interventions: Patient nudge; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 50 Years to 80 Years
Enrollment: 894 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Breast Cancer, Colorectal Cancer, Covid19
Interventions: Informational videos and social media campaigns encouraging cancer screening.; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Pawtucket, Rhode Island

Conditions: Lung Neoplasms, Lung Cancer
Interventions: Mobile Low-dose Computed Tomography (LDCT) Screening; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 40 Years to 54 Years
Enrollment: 1,160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Non-Small Cell Lung Cancer
Interventions: Alectinib, Atezolizumab, Pemetrexed, Cisplatin, Carboplatin, Gemcitabine, Entrectinib, Cobimetinib, Vemurafenib, Bevacizumab, Divarasib, Docetaxel; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 12
States / cities: Sacramento, California • Denver, Colorado • Fort Myers, Florida + 9 more

Conditions: Nodule Solitary Pulmonary, Non-small Cell Lung Cancer
Interventions: Guardant Health ct-DNA LUNAR assay; Diagnostic Test
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years and older
Enrollment: 1,440 participants
Timeline: 2017 – 2030
U.S. locations: 3
States / cities: San Francisco, California

Conditions: Chronic Obstructive Pulmonary Disease, COPD
Interventions: Group 1, Group 2, Group 3; Genetic
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Lung Cancer, Lung Cancer Screening
Interventions: Stepped Reminders, Patient Education; Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 50 Years to 78 Years
Enrollment: 1,837 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Lung Cancer, Cancer of the Lung
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 279 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Creve Coeur, Missouri

Conditions: Smoking Reduction, Tobacco Use, Tobacco Smoking, Tomography, Lung Diseases, Lung Neoplasms
Interventions: Unsigned note to provider about cessation medication prescription, Proactive Telephone Counseling from VA Quitline; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Up to 80 Years
Enrollment: 944 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 3
States / cities: New York, New York • Providence, Rhode Island • Seattle, Washington

Conditions: Lung Cancer
Interventions: Ability to order FirstLook™, Continuing Medical Education for Lung Cancer; Diagnostic Test · Other
Lead sponsor: Delfi Diagnostics Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Aurora, Colorado • Jacksonville, Florida • Durham, North Carolina

Conditions: Smoking, Tobacco, Tobacco-Related Carcinoma, Tobacco Use, Lung Cancer Screening
Interventions: Intensive Telephone Counseling (8 sessions) with nicotine replacement, Usual Care: Telephone counseling (3 sessions) with nicotine replacement; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 1,114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 7
States / cities: Washington D.C., District of Columbia • Miami, Florida • Moline, Illinois + 4 more

Conditions: Lung Neoplasms
Interventions: Breath Collection Apparatus; Device
Lead sponsor: Menssana Research, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 215 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 4
States / cities: Newark, Delaware • Orlando, Florida • New York, New York + 1 more

Conditions: Prevention and Control
Interventions: Webinar, Promotion, and Tool Access, LEAP, Audit and Feedback, Academic Detailing; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 55 Years to 80 Years
Enrollment: 17,033 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 8
States / cities: Ann Arbor, Michigan • Minneapolis, Minnesota • New York, New York + 5 more

Conditions: Breast Cancer, Cervical Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer
Interventions: Navigation; Other
Lead sponsor: Queen's Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 628 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Kaunakakai, Hawaii

Conditions: Lung Cancer, Cervical Cancer, Breast Cancer, Colorectal Cancer
Interventions: Lay health advisor interactions; Behavioral
Lead sponsor: Nancy Schoenberg; Other
Eligibility: 18 Years and older
Enrollment: 1,415 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Whitesburg, Kentucky

Conditions: Lung Cancer
Interventions: Chest X-ray Tomosynthesis; Diagnostic Test
Lead sponsor: University of California, San Diego; Other
Eligibility: 30 Years to 85 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Smoking Cessation, Smoking Cessation Counseling Ability and Practice, Smoking Cessation Counselling, Lung Cancer Screening
Interventions: CONNECT Intervention for multilingual populations, Saliva Sample, Interview; Behavioral · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years to 80 Years
Enrollment: 439 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Population at Risk
Interventions: Should I Screen website, Should I Screen print booklet; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 298 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Lung Cancer, EGFR Gene Mutation
Interventions: Circulating Tumor DNA (ctDNA) Assay; Device
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 40 Years to 80 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 6
States / cities: Boston, Massachusetts • Brighton, Massachusetts • Methuen, Massachusetts + 1 more

Conditions: Lung Cancer
Interventions: Lung MRI, Blood Draw; Diagnostic Test
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Patient Navigation for Lung Cancer Screening in an Urban Safety-Net System

Community Support Program for Lung Cancer Screening Volume II

Increasing Equity in Lung Cancer Screening

PCORI-CER-1306-03385 Lung Cancer Screening Readiness Study

Evaluation of a Patient 'nudge' on Engagement in Lung Cancer Screening

Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

Biomarkers for Risk Stratification in Lung Cancer

Incorporation of Genetic Expression of Airway Epithelium With CT Screening for Lung Cancer

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment

Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer

The Lung Screening, Tobacco and Health Project

Breath Test for Early Detection of Lung Cancer

PrOVE QUERI Project #1

Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project

Faith Moves Mountains: A Community Based Participatory Research (CBPR) Appalachian Wellness & Cancer Prevention Program

Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer

Evaluating the Impact of CONNECT in a Multilingual Population

Educating QUitline Callers About Lung Cancer Screening

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening